Radnostix, Inc. (INIS)
OTCMKTS · Delayed Price · Currency is USD
0.0711
-0.0179 (-20.11%)
At close: Mar 10, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Theranostics Products
8.01M6.84M6.05M4.28M4.07M
Theranostics Products Growth
17.00%13.18%41.42%5.00%42.75%
Cobalt Products
2.37M1.04M1.16M1.35M1.23M
Cobalt Products Growth
128.10%-10.41%-14.54%10.52%44.80%
Calibration & Reference Products
3.52M4.39M3.98M--
Calibration & Reference Products Growth
-19.79%10.27%---
Medical Device Products
8.66K----
Fluorine Products
---29.78K178.35K
Fluorine Products Growth
----83.31%11.12%
Nuclear Medicine Standards
---4.00M3.67M
Nuclear Medicine Standards Growth
---8.97%-6.42%
Radiological Services (Incl. Transportation)
----216.14K
Radiological Services (Incl. Transportation) Growth
-----81.54%
Total
13.90M12.27M11.18M9.66M9.36M
Total Growth
13.31%9.71%15.73%3.17%4.57%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States
9.65M8.20M8.08M
United States Growth
17.68%1.41%11.32%
outside United States
1.53M1.46M1.28M
outside United States Growth
4.79%14.29%-24.36%
Total
11.18M9.66M9.36M
Total Growth
15.73%3.17%4.57%
Source: S&P Global Market Intelligence.